Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Peter Svennilson
AddedMar 31, 2024
UpdatedMay 31, 2026
Peter Svennilson

Peter Svennilson

Founder, The Column Group

CrunchbaseLinkedIn

Peter Svennilson's Career

The Column Group
The Column Group

San Francisco, CA, US

Founder
Circle Pharma
Circle Pharma

San Francisco, CA, US

Board Member· Board
Ribon Therapeutics
Ribon Therapeutics

Cambridge, MA, US

Board Member· Board
Carmot Therapeutics
Carmot Therapeutics

Berkeley, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Peter Svennilson's Career

The Column Group
The Column Group
Investment FirmInvestment Firm272008San Francisco, CA, US
Founder
Circle Pharma
Circle Pharma
Series C$117.5M682012San Francisco, CA, US
Board Member· Board

Leadership at Circle Pharma

Douglas CrawfordDouglas CrawfordBoard Member
David J. EarpDavid J. EarpCEO
Walter H. MoosWalter H. MoosBoard Member
Thilo SchroederThilo SchroederBoard Member
John JoseyJohn JoseyBoard Member
Scott LokeyScott LokeyCo-Founder

Similar to Circle Pharma

20n Bio20n BioMalvern, PA, USPeptide Therapeuticsest. 202120n BioMalvern, PA, US · est. 2021

20n Bio, a VC-backed start-up in Malvern, PA, specializes in designing novel protein therapeutics.

Seed · $3.3M4
PeptilogicsPeptilogicsPittsburgh, PA, USPeptide Therapeuticsest. 2013PeptilogicsPittsburgh, PA, US · est. 2013

Peptilogics: An American biotech firm revolutionizing drug discovery with novel peptide therapeutics.

Series D · $44.1M28
Cyclo TherapeuticsCyclo TherapeuticsGainesville, FL, USBiotech, Treatmentsest. 1990Cyclo TherapeuticsGainesville, FL, US · est. 1990

Cyclo Therapeutics: A US-based clinical-stage biotech firm developing treatments for unmet medical needs.

Public · $16.8M9
Curie.BioCurie.BioBoston, MA, USDrug Developmentest. 2022Curie.BioBoston, MA, US · est. 2022

Curie.Bio: A seed-stage venture firm specializing in drug-focused services for founders.

Series B26
Ribon Therapeutics
Ribon Therapeutics
Series B$259M572015Cambridge, MA, US
Board Member· Board

Leadership at Ribon Therapeutics

Jon RootJon RootBoard Member
Jeff GoaterJeff GoaterBoard Member
Jodie MorrisonJodie MorrisonBoard Member
Paul ChangPaul ChangCo-Founder
Jim AudiaJim AudiaBoard Member
Tim MitchisonTim MitchisonCo-Founder

Similar to Ribon Therapeutics

RibonovaRibonovaWynnewood, PA, USPharmaceuticalsest. 2011RibonovaWynnewood, PA, US · est. 2011

US-based Ribonova Inc, founded in 2011, specializes in manufacturing pharmaceuticals for human and veterinary use.

Angel · $25k5
RibometrixRibometrixGreenville, NC, USDrug Discoveryest. 2014RibometrixGreenville, NC, US · est. 2014

Ribometrix, a US-based biotech firm, leverages 3D RNA analysis for novel drug discovery.

Series A · $45.3M29
ENB TherapeuticsENB TherapeuticsNew York City, NY, USCancer Therapeuticsest. 2015ENB TherapeuticsNew York City, NY, US · est. 2015

ENB Therapeutics, Inc.: A US-based biopharmaceutical firm developing novel inhibitors to treat cancers.

Series A · $8.2M8
Redona TherapeuticsRedona TherapeuticsWatertown, MA, USCancer Treatmentest. 2016Redona TherapeuticsWatertown, MA, US · est. 2016

Redona Therapeutics: Advancing small molecule therapies for cancer via ncRNA modulation.

Series A · $66.8M24
Carmot Therapeutics
Carmot Therapeutics
Series E$384.8M722008Berkeley, CA, US
Board Member· Board

Leadership at Carmot Therapeutics

Anne M. PhillipsAnne M. PhillipsBoard Member
Stig HansenStig HansenCo-Founder
Aetna Wun TrombleyAetna Wun TrombleyBoard Member
Daniel ErlansonDaniel ErlansonCo-Founder
Heather TurnerHeather TurnerCEO
Tim GarnettTim GarnettBoard Member

Peter Svennilson's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Peter Svennilson

Peder SandePeder SandeCo-Founder · RallyonScott LoweScott LoweCo-Founder · MirimusTom PetroTom PetroBoard Member · UnivestJames FoghtJames FoghtBoard Member · OncolyzeCam GallagherCam GallagherBoard Member · Ocuphire Pharma